Advertisements



The Week Ahead In Biotech: Conferences, Clinical Trials And IPOs

The ASCO conference closed Tuesday, although presentations at the conference triggered some huge stocks moves. read more.....»»

Category: blogSource: benzingaJun 10th, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results And IPOs

After ending almost flat in the week ended Sept. 14, biotech stocks have seen.....»»

Category: earningsSource: benzinga36 min. ago

The Week Ahead In Biotech (Sept. 23-29): Conferences, PDUFA Dates, Clinical Trial Results And IPOs

After ending almost flat in the week ended Sept. 14, biotech stocks have seen some bounce in the running week, with the iShares NASDAQ Biotechnology Index (NASDAQ: IBB) up about 1.3 percent through Thursday. read more.....»»

Category: blogSource: benzinga14 hr. 35 min. ago

The Week Ahead In Biotech (Sept. 23-29): Conferences, PDUFA Dates, Clinical Trial Results And IPOs

After ending almost flat in the week ended Sept. 14, .....»»

Category: earningsSource: benzinga16 hr. 5 min. ago

The Week Ahead In Biotech (Sept. 16-22): Conferences, PDUFA Dates, Clinical Trial Results And IPOs

Biotech were trending mostly sideways in the week ending Sept. 14 after posting weekly gains in the previous two weeks. Notwithstanding the overall muted sentiment, there was some activity in reaction to the release of clinical trial results. read more.....»»

Category: blogSource: benzingaSep 16th, 2018

The Week Ahead In Biotech: Conferences, Clinical Trial Results, Earnings And IPOs

After recording stellar gains of 4.3 percent in the week ended Aug. 31 to close the month in the green, the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) saw a moderation in momentum in the holiday-shortened week ending Sept. 7. read more.....»»

Category: blogSource: benzingaSep 9th, 2018

The Week Ahead In Biotech: Conferences, Clinical Trial Results, Earnings And IPOs

After recording stellar gains of 4.3 percent in the week ended Aug. 31 to close the month .....»»

Category: earningsSource: benzingaSep 9th, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings

The biotech sector notched strong gains last week, capitalizing on the positive overall mark.....»»

Category: earningsSource: benzingaSep 2nd, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings

The biotech .....»»

Category: blogSource: benzingaSep 2nd, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings And IPOs

Biotech stocks saw modest gains this week, with earnings providing a boost even as clinical trial results elicited a mixed reaction. read more.....»»

Category: blogSource: benzingaJul 28th, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings And IPOs

Biotech stocks saw modest gains this week, with earnings providing a boost even as clinical trial results elicited a mixed reaction. Eli Lilly And Co (NYSE: LLY), Vertex Pharmaceuticals Incorporated (NA.....»»

Category: earningsSource: benzingaJul 28th, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results, Earnings And IPOs

The upcoming week could see some action due to the presence of a host of catalytic events that include PDUFA dates and earnings releases. Here are are the ones a biotech investor should keep a tab on. read more.....»»

Category: blogSource: benzingaJul 22nd, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results, Earnings And IPOs

The upcoming week could see some action due to the presence of a host of catalytic events that include PDUFA dates and earnings releases. Here are are the ones a biotech investor should keep a tab on. Conferences Alzheimer's Association In.....»»

Category: earningsSource: benzingaJul 22nd, 2018

The Week Ahead In Biotech: Conferences, Clinical Trial Results, IPOs And More

A bit of a lull took place in the biotech space ahead of earnings season; IPO activity was non-existent, but there was some action on account of clinical trial results. He.....»»

Category: earningsSource: benzingaJul 14th, 2018

The Week Ahead In Biotech: Conferences, Clinical Trial Results, IPOs And More

A bit of a lull took place in the biotech space ahead of earnings season; IPO activity was non-existent, but there was some action on account of clinical trial results. Here's a look at the upcoming week's catalytic events. read more.....»»

Category: blogSource: benzingaJul 14th, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials

Biotech stocks held their ground in a holiday-shortened week amid a drought of market-moving catalysts. Looking ahead, the following are catalytic events for biotech investors to watch.  read more.....»»

Category: blogSource: benzingaJul 8th, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Results

Biotech stocks saw a resurgence this week, as a post-earnings follow-up rally and company-specific news offered support. The iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) gained about 1.5 percent. The followi.....»»

Category: earningsSource: benzingaAug 26th, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Results

Biotech stocks saw a resurgence this week, as a post-earnings follow-up rally and company-specific news offered support. read more.....»»

Category: blogSource: benzingaAug 26th, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates And IPOs

Earnings is providing a much-needed boost to the biotech sector last week, with big-name companies like Eli Lilly And Co (NYSE: LLY) and Pfizer Inc. read more.....»»

Category: blogSource: benzingaAug 5th, 2018

The Week Ahead: Pharma IPOs Galore, Blackberry Earnings And More

Below is a list of notable corporate events for the week beginning June 18. Note, this list is not comprehensive and all dates are subject to change. All times are ET. Monday Conferences Blockchain Economic Forum June 16-19 FDA/Biotech Latest Rat.....»»

Category: blogSource: benzingaJun 18th, 2018

The Week Ahead In Biotech: PDUFA Dates, Clinical Trials, Merck And Pfizer Earnings On Tap

After a lackluster show mid-way through the week despite M&A news and earnings, the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) staged a recovery in the later part of the week. read more.....»»

Category: blogSource: benzingaApr 29th, 2018